• 1
    Artigas F., Romero L., De Montigny C., Blier P. (1996) Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists. Trends Neurosci. 19 378383.
  • 2
    Avissar S., Nechamkin Y., Roitman G., Schreiber G. (1998) Dynamics of ECT normalization of low G protein function and immunoreactivity in mononuclear leukocytes of patients with major depression. Am. J. Psychiatry 155 666671.
  • 3
    Barden N., Reul J.M.H.M., Holsboer F. (1995) Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system? Trends Neurosci. 18 611.
  • 4
    Bel N. & Artigas F. (1993) Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse 15 243245.
  • 5
    Belmaker R.H., Bersudsky Y., Agam G., Levine J., Kofman O. (1996) How does lithium work on manic depression? Clinical and psychological correlates of the inositol theory. Annu. Rev. Med. 47 4756.
  • 6
    Bennett M.K., Miller K.G., Scheller R.H. (1993) Casein kinase II phosphorylates the synaptic vesicle protein p65. J. Neurosci. 13 17011707.
  • 7
    Blier P. & Bouchard C. (1994) Modulation of 5-HT release in the guinea pig brain following long-term administration of antidepressant drugs. Br. J. Pharmacol. 113 485495.
  • 8
    Blier P. & De Montigny C. (1994) Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15 220225.
  • 9
    Bottiglieri T. (1997) Ademetionine (S-adenosylmethionine) neuropharmacology: implications for drug therapies in psychiatric and neurological disorders. Exp. Opin. Invest. Drugs 6 110.
  • 10
    Bouron A. & Chatton J. -Y. (1999) Acute application of the tricyclic antidepressant desipramine presynaptically stimulates the exocytosis of glutamate in the hippocampus. Neuroscience 90 729736.DOI: 10.1016/S0306-4522(98)00480-1
  • 11
    Braun A.P. & Schulman H. (1995) The multifunctional calcium/calmodulin-dependent protein kinase: from form to function. Annu. Rev. Physiol. 57 417445.
  • 12
    Bunney W.E. & Davis J.M. (1965) Norepinephrine in depressive reactions: a review. Arch. Gen. Psychiatry 13 483494.
  • 13
    Chen J. & Rasenick M.M. (1995) Chronic antidepressant treatment facilitates G protein activation of adenylyl cyclase without altering G protein content. J. Pharmacol. Exp. Ther. 275 509517.
  • 14
    Dell'Acqua M.L. & Scott J.D. (1997) Protein kinase A anchoring. J. Biol. Chem. 272 1288112884.
  • 15
    Dubovsky S.L., Christiano J., Daniell L.C., Franks R.D., Murphy J., Adler L., Baker N., Harris R.A. (1989) Increased platelet intracellular calcium concentration in patients with bipolar affective disorders. Arch. Gen. Psychiatry 46 632638.
  • 16
    Dubovsky S.L., Murphy J., Thomas M., Rademacher J. (1992) Abnormal intracellular calcium ion concentration in platelets and lymphocytes of bipolar patients. Am. J. Psychiatry 149 118120.
  • 17
    Duman R.S. (1998) Novel therapeutic approaches beyond the serotonin receptor. Biol. Psychiatry 44 324335.
  • 18
    Edelman A.M., Blumenthal D.K., Krebs E.G. (1987) Protein serine-threonine kinases. Annu. Rev. Biochem. 56 567613.
  • 19
    Erlichman J., Sarkar D., Fleischer N., Rubin C.S. (1980) Identification of two subclasses of type II cAMP-dependent protein kinases: neural specific and non-neural protein kinases. J. Biol. Chem. 255 81798184.
  • 20
    Faux M.C. & Scott J.D. (1996) More on target with protein phosphorylation: conferring specificity by location. Trends Biochem. Sci. 21 312315.
  • 21
    Geppert M., Goda Y., Hammer R.E., Rosahl T.W., Stevens C.F., Sudhof T.C. (1994) Synaptotagmin I: a major Ca2+ sensor for transmitter release at a central synapse. Cell 79 717727.
  • 22
    Gorelick F.S., Wang J.K.T., Lai Y., Nairn A.C., Greengard P. (1988) Autophosphorylation and activation of Ca2+/calmodulin-dependent protein kinase II in intact nerve terminals. J. Biol. Chem. 263 1720917212.
  • 23
    Greengard P., Valtorta F., Czernik A.J., Benfenati F. (1993) Synaptic vesicle phosphoproteins and regulation of synaptic function. Science 259 780785.
  • 24
    Hanks S.K., Quinn A.M., Hunter T. (1988) The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241 4252.
  • 25
    Hausdorff W.P., Caron M.G., Lefkowitz R.J. (1990) Turning off the signal: desensitization of beta-adrenergic receptor function. FASEB J. 4 28812889.
  • 26
    Haydon P.G., Man-Son-Hing H., Doyle R.T., Zoran M. (1991) FMRFamide modulation of secretory machinery underlying presynaptic inhibition of synaptic transmission requires a pertusis toxin-sensitive G-protein. J. Neurosci. 11 38513860.
  • 27
    Heist E.K. & Schulman H. (1988) The role of Ca2+/calmodulin-dependent protein kinases within the nucleus. Cell Calcium 23 103114.
  • 28
    Hirling H. & Scheller R.H. (1996) Phosphorylation of synaptic vesicle proteins: modulation of the αSNAP interaction with the core complex. Proc. Natl. Acad. Sci. USA 93 1194511949.
  • 29
    Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., Saxena P.R., Humphrey P.P.A. (1994) International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46 157203.
  • 30
    Huganir R.L. & Greengard P. (1990) Regulation of neurotransmitter receptor desensitization by protein phosphorylation. Neuron 5 555567.
  • 31
    Hyman S.E. & Nestler E.J. (1996) Initiation and adaptation: a paradigm for understanding psychotropic drug action. Am. J. Psychiatry 153 151162.
  • 32
    Kennedy M.B. (1997) The postsynaptic density at glutamatergic synapses. Trends Neurosci. 20 264268.
  • 33
    Kreiss D.S. & Lucki I. (1995) Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J. Pharmacol. Exp. Ther. 274 866876.
  • 34
    Laduron P.M. (1998) Presynaptic receptors: more hetero than auto. Trends Pharmacol. Sci. 19 127128.
  • 35
    Lavoie P.A., Beauchamp G., Elie R. (1997) Atypical antidepressants inhibit depolarization-induced calcium uptake in rat hippocampus synaptosomes. Can. J. Physiol. Pharmacol. 75 983987.
  • 36
    Lawrence J.C. (1992) Signal transduction and protein phosphorylation in the regulation of cellular metabolism by insulin. Annu. Rev. Physiol. 54 177193.
  • 37
    Lenox R.H., McNamara R.K., Watterson J.M., Watson D.G. (1996) Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain? J. Clin. Psychiatry 57 (Suppl. 13) , 2331.
  • 38
    Lenox R.H., McNamara R.K., Papke R.L., Manji H.K. (1998) Neurobiology of lithium: an update. J. Clin. Psychiatry 59 (Suppl. 6) , 3747.
  • 39
    Levitan I.B. (1994) Modulation of ion channels by protein phosphorylation and dephosphorylation. Annu. Rev. Physiol. 56 193212.
  • 40
    Llinas R., Gruner J.A., Sugimori M., McGuinness T.L., Greengard P. (1991) Regulation by synapsin I and Ca2+-calmodulin-dependent protein kinase II of the transmitter release in squid giant synapse. J. Physiol. (Lond.) 436 257282.
  • 41
    Lowther S., Katona C.L., Crompton M.R., Horton R.W. (1997) Brain [3H]cAMP binding sites are unaltered in depressed suicides, but decreased by antidepressants. Brain Res. 758 223228.
  • 42
    Manji H.K. (1992) G proteins: implications for psychiatry. Am. J. Psychiatry 149 746760.
  • 43
    Manji H.K., Chen G., Hsiao J.K., Risby E.D., Masana M.I., Potter W.Z. (1996) Regulation of signal transduction pathways by mood-stabilizing agents: implications for the delayed onset of the therapeutic efficacy. J. Clin. Psychiatry 57 (Suppl. 13) , 3446.
  • 44
    Mann C.D., Bich Vu T., Hrdina P.D. (1995) Protein kinase C in rat brain cortex and hippocampus: effect of repeated administration of fluoxetine and desipramine. Br. J. Pharmacol. 115 595600.
  • 45
    McGlade-McCulloh E., Yamamoto H., Tan S., Brickey D.A., Soderling T.R. (1993) Phosphorylation and regulation of glutamate receptors by calcium/calmodulin-dependent protein kinase II. Nature 362 640642.
  • 46
    Miyamoto S., Asakura M., Sasuga Y., Osada K., Bodaiji N., Imafuku J., Aoba A. (1997) Effects of long-term treatment with desipramine on microtubule proteins in rat cerebral cortex. Eur. J. Pharmacol. 333 279287.
  • 47
    Mochly-Rosen D. (1995) Localization of protein kinases by anchoring proteins: a theme in signal transduction. Science 268 247251.
  • 48
    Mongeau R., Blier P., De Montigny C. (1997) The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of the antidepressant treatments. Brain Res. Rev. 23 145195.
  • 49
    Mori S., Garbini S., Caivano M., Perez J., Racagni G. (1998a) Time-course changes in rat cerebral cortex subcellular distribution of the cyclic-AMP binding after treatment with selective serotonin reuptake inhibitors. Int. J. Neuropsychopharmacol. 1 310.
  • 50
    Mori S., Zanardi R., Popoli M., Garbini S., Smeraldi E., Racagni G., Perez J. (1998b) cAMP-dependent phosphorylation system after short and long-term administration of moclobemide. J. Psychiatr. Res. 32 111115.
  • 51
    Moyer J.A., Sigg E.B., Silver P.J. (1986) Antidepressants and protein kinases: desipramine treatment affects pineal gland cAMP-dependent protein kinase activity. Eur. J. Pharmacol. 121 5764.
  • 52
    Mudd S.H. & Cantoni G.L. (1964) Biological transmethylation methyl group neogenesis and other‘one carbon metabolic reactions dependent upon tetrahydrofolic acid’, in Comprehensive Biochemistry, Vol. 15 (Florkin M. and Stotz E. H., eds), pp. 147. Elsevier, New York.
  • 53
    Nairn A.C., Hemmings H.C., Greengard P. (1985) Protein kinases in the brain. Annu. Rev. Biochem. 54 931976.
  • 54
    Nestler E.J., Terwilliger R.Z., Duman R.S. (1989) Chronic antidepressant administration alters the subcellular distribution of cyclic AMP-dependent protein kinase in rat frontal cortex. J. Neurochem. 53 16441647.
  • 55
    Nibuya M., Morinobu S., Duman R.S. (1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 15 75397547.
  • 56
    Nibuya M., Nestler E.J., Duman R.S. (1996) Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neurosci. 16 23652372.
  • 57
    Nichols R.A., Haycock J.W., Wang J.K.T., Greengard P. (1987) Phorbol ester enhancement of neurotransmitter release from rat brain synaptosomes. J. Neurochem. 48 615621.
  • 58
    Nichols R.A., Sihra T.S., Czernik A.J., Nairn A.C., Greengard P. (1990) Calcium/calmodulin-dependent protein kinase II increases glutamate and noradrenaline release from synaptosomes. Nature 343 647651.
  • 59
    Nishizuka Y. (1995) Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 9 484496.
  • 60
    Nunoki K., Florio V., Catterall W.A. (1989) Activation of purified calcium channels by stoichiometric protein phosphorylation. Proc. Natl. Acad. Sci. USA 86 68166820.
  • 61
    Obar R.A., Dingus J., Bayley H., Valee R.B. (1989) The RII subunit of cAMP-dependent protein kinase binds to a common amino-terminal domain in microtubule-associated proteins 2A, 2B and 2C. Neuron 3 639645.
  • 62
    Page M.E. & Abercrombie E.D. (1997) An analysis of the effects of acute and chronic fluoxetine on extracellular norepinephrine in the rat hippocampus during stress. Neuropsychopharmacology 16 419425.
  • 63
    Pancrazio J.J., Kamatchi G.L., Roscoe A.K., Lynch C. (1998) Inhibition of neuronal Na+ channels by antidepressant drugs. J. Pharmacol. Exp. Ther. 284 208214.
  • 64
    Pasinelli P., Ramakers G.M., Urban I.J., Hens J.J., Oestreicher A.B., De Graan P.N., Gispen W.H. (1995) Long-term potentiation and synaptic protein phosphorylation. Behav. Brain Res. 66 5359.
  • 65
    Perez J., Tinelli D., Bianchi E., Brunello N., Racagni G. (1991) cAMP binding proteins in the rat cerebral cortex after administration of selective 5-HT and NE reuptake blockers with antidepressant activity. Neuropsychopharmacology 4 5764.
  • 66
    Perez J., Tinelli D., Cagnoli C., Pecin P., Brunello N., Racagni G. (1993) Evidence for the existence of cAMP-dependent protein kinase phosphorylation system associated with specific phosphoproteins in stable microtubules from rat cerebral cortex. Brain Res. 602 7783.
  • 67
    Popoli M. (1993a) p65-synaptotagmin: a docking-fusion protein in synaptic vesicle exocytosis? Neuroscience 54 323328.
  • 68
    Popoli M. (1993b) Synaptotagmin is endogenously phosphorylated by Ca2+/calmodulin protein kinase II in synaptic vesicles. FEBS Lett. 317 8588.
  • 69
    Popoli M., Vocaturo C., Perez J., Smeraldi E., Racagni G. (1995) Presynaptic Ca2+/calmodulin-dependent protein kinase II: autophosphorylation and activity increase in the hippocampus after long-term blockade of serotonin reuptake. Mol. Pharmacol. 48 623629.
  • 70
    Popoli M., Venegoni A., Vocaturo C., Buffa L., Perez J., Smeraldi E., Racagni G. (1997a) Long-term blockade of serotonin reuptake affects synaptotagmin phosphorylation in the hippocampus. Mol. Pharmacol. 51 1926.
  • 71
    Popoli M., Zanotti S., Radaelli R., Gaggianesi C., Verona M., Brunello N., Racagni G. (1997b) The neurotransmitter release machinery as a site of action for psychotropic drugs: effect of typical and atypical antidepressants. Soc. Neurosci. Abstr. 23 25.
  • 72
    Popoli M., Verona M., Zanotti S., Gaggianesi C., Schafer T., Racagni G. (1998) Regulation by calcium of synaptotagmin interaction with SNARE proteins. Soc. Neurosci. Abstr. 24 1568.
  • 73
    Racagni G., Brunello N., Tinelli D., Perez J. (1992) New biochemical hypotheses on the mechanism of action of antidepressant drugs: cAMP-dependent phosphorylation system. Pharmacopsychiatry 25 5155.
  • 74
    Racagni G., Popoli M., Mori S., Brunello N., Perez J. (1996) Targeting the action of antidepressant drugs on second messenger systems, in Implications of Psychopharmacology to Psychiatry (Ackeneil M., Bondy B., Ermann M., and Nedopil N., eds), pp. 3440. Springer, New York.
  • 75
    Rahimian R. & Hrdina P.D. (1995) Possible role of protein kinase C in regulation of 5-hydroxytryptamine 2A receptors in rat brain. Can. J. Physiol. Pharmacol. 73 16861691.
  • 76
    Rahman S., Li P.P., Young L.T., Kofman O., Kish S.J., Warsh J.J. (1997) Reduced [3H]cyclic AMP binding in postmortem brain from subjects with bipolar affective disorder. J. Neurochem. 68 297304.
  • 77
    Ramamoorthy S., Giovanetti E., Qian Y., Blakely R.D. (1998) Phosphorylation and regulation of antidepressant-sensitive serotonin transporters. J. Biol. Chem. 273 24582466.
  • 78
    Rosin D.L., Melia K., Knorr A.M., Nestler E.J., Roth R.H., Duman R.S. (1995) Chronic imipramine administration alters the activity and phosphorylation state of tyrosine hydroxylase in dopaminergic regions of rat brain. Neuropsychopharmacology 12 113121.
  • 79
    Rostas J.A.P. & Dunkley P.R. (1992) Multiple forms and distribution of Ca2+/calmodulin-stimulated protein kinase II in brain. J. Neurochem. 59 11911202.
  • 80
    Rotenberg A., Mayford M., Hawkins R.D., Kandel E.R., Muller R.U. (1996) Mice expressing activated CaMKII lack low frequency LTP and do not form stable place cells in the CA1 region of the hippocampus. Cell 87 13511361.
  • 81
    Rubino H.M., Dammerman M., Shafit-Zagardo B., Erlichman J. (1989) Localization and characterization of the binding site for the regulatory subunit of type II cAMP-dependent protein kinase on MAP2. Neuron 3 631638.
  • 82
    Sanders-Bush E., Conn J., Sulser F. (1985) The serotonin/norepinephrine-linked beta-adrenoceptor system and the mode of action of antidepressants. Psychopharmacol. Bull. 21 373378.
  • 83
    Sandler M. (1998) Forty years in the conceptual wilderness. Science 280 17091710.DOI: 10.1126/science.280.5370.1709
  • 84
    Scheller R.H. (1995) Membrane trafficking in the presynaptic terminal. Neuron 14 893897.
  • 85
    Schildkraut J.J. (1965) The catecholamine hypothesis of affective disorders: a review of supportive evidence. Am. J. Psychiatry 122 509522.
  • 86
    Scholz K.P. & Miller R.J. (1992) Inhibition of quantal transmitter release in the absence of calcium influx by a G protein-linked adenosine receptor at hippocampal synapses. Neuron 8 11391150.
  • 87
    Schwartz J.P. & Costa E. (1980) Protein kinase translocation following β-adrenergic receptor activation in C6 glioma cells. J. Biol. Chem. 255 29432948.
  • 88
    Selbie L.A. & Hill S.J. (1998) G protein-coupled-receptor cross-talk. The fine tuning of multiple receptor-signalling pathways. Trends Pharmacol. Sci. 19 8793.
  • 89
    Shelton R.C., Mainer D.H., Sulser F. (1996) cAMP-dependent protein kinase activity in major depression. Am. J. Psychiatry 153 10371042.
  • 90
    Shimazaki Y., Nishiki T., Omori A., Sekiguchi M., Kamata Y., Kozaki S., Takahashi M. (1996) Phosphorylation of 25-kDa synaptosome-associated protein. J. Biol. Chem. 271 1454814553.
  • 91
    Shimizu M., Nishida A., Fukuda H., Saito H., Yamawaki S. (1994) Inhibitory effect of imipramine on depolarization-induced increases in intracellular Ca2+ of rat cortical neurons. Eur. J. Pharmacol. 268 6571.
  • 92
    Silver P.J., Sigg E.B., Moyer J.A. (1986) Antidepressants and protein kinases: inhibition of Ca2+-regulated myosin phosphorylation by fluoxetine and iprindole. Eur. J. Pharmacol. 121 6571.
  • 93
    Sollner T., Bennet M.K., Whiteheart S.W., Scheller R.H., Rothman J.E. (1993) A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation and fusion. Cell 75 409418.
  • 94
    Stahl S.M. (1997) Psychopharmacology of Antidepressants. Martin Dunitz, London.
  • 95
    Stevens C.F. & Sullivan J.M. (1998) Regulation of the readily releasable vesicle pool by protein kinase C. Neuron 21 885893.
  • 96
    Tanaka C. & Nishizuka Y. (1994) The protein kinase C family for neuronal signaling. Annu. Rev. Neurosci. 17 551567.
  • 97
    Taylor S.S., Buechler J.A., Yonemoto W. (1990) cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. Annu. Rev. Biochem. 59 9711005.
  • 98
    Taylor S.S., Knighton D.R., Zheng J., Ten Eyck L.F., Sowadski J.M. (1992) Structural framework for the protein kinase family. Annu. Rev. Cell Biol. 8 429462.
  • 99
    Travagli R.A., Gillis R.A., Kellar K.J. (1994) S-Adenosyl-l-methionine modulates firing rate of dorsal motor nucleus of the vagus neurones in vitro. Eur. J. Pharmacol. 264 385390.
  • 100
    Tsutsui M., Yanagihara N., Miyamoto E., Kuroiwa A., Izumi F. (1994) Correlation of activation of Ca2+/calmodulin-dependent protein kinase II with secretion and tyrosine hydroxylase activation in cultured bovine adrenal medullary cells. Mol. Pharmacol. 46 10411047.
  • 101
    Verona M., Zanotti S., Gaggianesi C., Schafer T., Racagni G., Popoli M. (1998) Modulation of protein-protein interaction in presynaptic terminals: a possible site of action for psychotropic drugs. Int. J. Neuropsychopharmacol. 1 (Suppl.) , S64.
  • 102
    Williams J.T., Colmers W.F., Pan Z.Z. (1988) Voltage- and ligand-activated inwardly rectifying currents in dorsal raphe neurons in vitro. J. Neurosci. 8 34993506.
  • 103
    Wright S.C., Schellenberger U., Ji L., Wang H., Larrick J.W. (1997) Calmodulin-dependent protein kinase II mediates signal transduction in apoptosis. FASEB J. 11 843849.
  • 104
    Yamaji T., Kagaya A., Uchitomi Y., Yokota N., Yamawaki S. (1997) Chronic treatment with antidepressants, verapamil, or lithium inhibits the serotonin-induced intracellular calcium response in individual C6 rat glioma cells. Life Sci. 60 817823.
  • 105
    Yokoyama C.T., Sheng Z., Catterall W.A. (1997) Phosphorylation of the synaptic protein interaction site on N-type calcium channels inhibits interactions with SNARE proteins. J. Neurosci. 17 69296938.
  • 106
    Zanotti S., Mori S., Radaelli R., Perez J., Racagni G., Popoli M. (1998) Modifications in brain cAMP- and calcium/calmodulin-dependent protein kinases induced by treatment with S-adenosylmethionine. Neuropharmacology 37 10811089.